InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,584.54
(
-0.88%
)
US TECH 100
19,699.60
(
-2.08%
)
Dow Jones
39,753.75
(
0.08%
)
Brent Oil
85.11
(
0.07%
)
Bitcoin
57,331.15
(
-0.74%
)
Post# of 92948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

lasers

Send PM Follow Ignore
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

lasers

Re: rumper post# 81113

Wednesday, 02/11/2015 9:26:28 PM

Wednesday, February 11, 2015 9:26:28 PM

Post# of 92948
rumper exactly correct and exactly why John Heffernan left Sanofi Genzyme after 18 years to join $OCAT. By now everyone in Sanofi Genzyme and Regeneron knows this also as to $OCAT having some +150 Patents and Applications and getting more every month. What better opportunity for Sanofi or another major Pharma to form a partnership with $OCAT.

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up